US Patent Issued to Aron H. Blaesi on March 18 for "Dosage form comprising structured solid-solution framework of sparingly-soluble drug and method for manufacture thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,465, issued on March 18, was assigned to Aron H. Blaesi (Cambridge, Mass.).

"Dosage form comprising structured solid-solution framework of sparingly-soluble drug and method for manufacture thereof" was invented by Aron H. Blaesi (Cambridge, Mass.) and Nannaji Saka (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "By the ingestion of dosage forms containing sparingly water-soluble drug particles, it is not possible to deliver drug into the blood stream at high rates, because the drug dissolution rate, and the absorption rate, are limited by solubility. Herein, therefore, dosage forms comprising a slender, three-dimensional structural ...